MX2024013723A - Metodo para mejorar los resultados de salud de un perro usando edad biologica - Google Patents
Metodo para mejorar los resultados de salud de un perro usando edad biologicaInfo
- Publication number
- MX2024013723A MX2024013723A MX2024013723A MX2024013723A MX2024013723A MX 2024013723 A MX2024013723 A MX 2024013723A MX 2024013723 A MX2024013723 A MX 2024013723A MX 2024013723 A MX2024013723 A MX 2024013723A MX 2024013723 A MX2024013723 A MX 2024013723A
- Authority
- MX
- Mexico
- Prior art keywords
- dog
- biological age
- improve health
- health outcomes
- regime
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263347106P | 2022-05-31 | 2022-05-31 | |
| PCT/EP2023/064444 WO2023232812A1 (en) | 2022-05-31 | 2023-05-30 | Method to improve health outcomes of a dog using biological age |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2024013723A true MX2024013723A (es) | 2024-12-06 |
Family
ID=86732682
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2024013723A MX2024013723A (es) | 2022-05-31 | 2024-11-06 | Metodo para mejorar los resultados de salud de un perro usando edad biologica |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250346954A1 (https=) |
| EP (1) | EP4532764A1 (https=) |
| JP (1) | JP2025521131A (https=) |
| CN (1) | CN119137289A (https=) |
| AU (1) | AU2023279813A1 (https=) |
| CA (1) | CA3254840A1 (https=) |
| MX (1) | MX2024013723A (https=) |
| WO (1) | WO2023232812A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025180998A1 (en) * | 2024-02-28 | 2025-09-04 | Société des Produits Nestlé S.A. | Methods utilizing dna methylation of canines |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3162899A1 (en) * | 2015-10-29 | 2017-05-03 | Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen | Biomarker for breast cancer |
| EP3583229A1 (en) * | 2017-02-20 | 2019-12-25 | Deutsches Krebsforschungszentrum | Dna methylation signatures for determining a survival probability |
| US11999995B2 (en) | 2017-08-31 | 2024-06-04 | The Regents Of The University Of California | Methylome profiling in animals and uses thereof |
-
2023
- 2023-05-30 CN CN202380038225.3A patent/CN119137289A/zh active Pending
- 2023-05-30 AU AU2023279813A patent/AU2023279813A1/en active Pending
- 2023-05-30 EP EP23729746.0A patent/EP4532764A1/en active Pending
- 2023-05-30 US US18/870,515 patent/US20250346954A1/en active Pending
- 2023-05-30 JP JP2024569178A patent/JP2025521131A/ja active Pending
- 2023-05-30 WO PCT/EP2023/064444 patent/WO2023232812A1/en not_active Ceased
- 2023-05-30 CA CA3254840A patent/CA3254840A1/en active Pending
-
2024
- 2024-11-06 MX MX2024013723A patent/MX2024013723A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA3254840A1 (en) | 2023-12-07 |
| CN119137289A (zh) | 2024-12-13 |
| EP4532764A1 (en) | 2025-04-09 |
| WO2023232812A1 (en) | 2023-12-07 |
| US20250346954A1 (en) | 2025-11-13 |
| AU2023279813A1 (en) | 2024-10-17 |
| JP2025521131A (ja) | 2025-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2024013723A (es) | Metodo para mejorar los resultados de salud de un perro usando edad biologica | |
| HK1258869A1 (zh) | 寡核酸变体文库及其合成 | |
| WO2005062770A3 (en) | Method for conducting pharmacogenomics-based studies | |
| MX2024013624A (es) | Metodo para mejorar el tiempo de vida saludable de un perro | |
| Chow et al. | Predictive model for survival in patients having repeat radiation treatment for painful bone metastases | |
| EP2241890A3 (en) | Method for determining the sensitivity of patients suffering from a cancer disease to biological therapy | |
| AR128276A1 (es) | Diagnósticos de resistencia y virulencia relacionados con patógenos vegetales | |
| Amatangelo et al. | Resistance to lenalidomide in multiple myeloma is associated with a switch in gene expression profile | |
| Datta et al. | Racial/Ethnic Disparities in Cancer-Associated Thrombosis: A Population-Based Study | |
| Pedersen et al. | The Prognostic Value of MYC, BCL2 and BCL6 Translocations and Protein Expressions in Young Patients with High-Risk Diffuse Large B-Cell Lymphoma Treated with R-CHOEP | |
| Weng et al. | Relationship between LAT1 expression and resistance to chemotherapy in pancreatic ductal adenocarcinoma | |
| Ninkovic et al. | Higher intensity of cell surface glucose-regulated protein 78 (csGRP78) expression is seen in patients with early progressive disease/mortality in a cohort of relapsed, refractory multiple myeloma patients treated with carfilzomib, thalidomide and dexamethasone | |
| Freitas et al. | Profiling signaling proteins in human spermatozoa: Biomarker identification for sperm quality evaluation | |
| TW200720440A (en) | Method | |
| UA105781U (uk) | Спосіб прогнозування зрощення перелому | |
| Kawajiri-Manako et al. | Clonal Immunoglobulin λ Light-Chain Gene Rearrangements Detected By Next Generation Sequencing in POEMS Syndrome | |
| Walsh et al. | Genome copy number alteration burden represents predictor of response in long-term, never relapse exceptional responders of trastuzumab-treated HER2+ metastatic breast cancer | |
| UA104419U (uk) | Спосіб прогнозування зрощення перелому | |
| UA106274U (uk) | Спосіб прогнозування зрощення перелому | |
| SHAYIDING | MSPC: an R/bioconductor package for combined analysis of ChIP-Seq data | |
| UA105785U (uk) | Спосіб прогнозування зрощення перелому | |
| Tsang et al. | Investigation of the functional significance of phytase activity in human fungal pathogen Candida albicans | |
| UA100374U (ru) | СПОСОБ прогнозирования сращения перелома | |
| Sevillano et al. | A prospective study of treatment outcomes in 179 patients with advanced cardiac stage STAGE IIIb amyloidosis | |
| UA82728U (ru) | Способ прогнозирования развития рефрактур |